Atea Pharmaceuticals, Inc. Common Stock AVIR
$5.07
+0.20%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-12 | View → |
| 8-K | 8-K | 2026-08-12 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 8-K | 8-K | 2026-06-22 | View → |
| 4 | 4 | 2026-05-20 | View → |
| 10-Q | 10-Q | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-12 | View → |
| DEF 14A | DEF 14A | 2026-04-27 | View → |
| 4 | 4 | 2026-03-13 | View → |
| 10-K | 10-K | 2026-03-05 | View → |
| 8-K | 8-K | 2026-03-05 | View → |
| 4 | 4 | 2026-02-03 | View → |
| 4 | 4 | 2026-02-03 | View → |
| 4 | 4 | 2026-02-03 | View → |
| 4 | 4 | 2026-02-03 | View → |
| 4 | 4 | 2026-02-03 | View → |
| 4 | 4 | 2026-02-03 | View → |
| 8-K | 8-K | 2026-01-08 | View → |
| 10-Q | 10-Q | 2025-11-12 | View → |
| 8-K | 8-K | 2025-11-12 | View → |
| 10-Q | 10-Q | 2025-08-07 | View → |
| 8-K | 8-K | 2025-08-07 | View → |
| 4 | 4 | 2025-06-24 | View → |
| 4 | 4 | 2025-06-24 | View → |
| 4 | 4 | 2025-06-24 | View → |
| 4 | 4 | 2025-06-24 | View → |
| 4 | 4 | 2025-06-24 | View → |
| 4 | 4 | 2025-06-24 | View → |
| 4 | 4 | 2025-06-24 | View → |
| 8-K | 8-K | 2025-06-20 | View → |
| 10-Q | 10-Q | 2025-05-12 | View → |
| 8-K | 8-K | 2025-05-12 | View → |
| DEF 14A | DEF 14A | 2025-04-29 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $5.07
- Market Cap
- $404.94 million
- 52-Week Range
- $2.78 – $6.45
- Average Volume
- 357K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.